Skip to content

Independent medical information

Sculptra vs Hyaluronic Acid Filler: What Is the Difference?

Hyaluronic acid filler adds volume immediately and can be dissolved; Sculptra stimulates collagen gradually over several sessions and cannot be dissolved.

Short answer

Hyaluronic acid filler adds volume directly, so the change is visible straight away, and it can usually be dissolved with an enzyme if needed. Sculptra (poly-L-lactic acid) works indirectly: it triggers a low-grade reaction that prompts the body to lay down collagen, so results build over a course of sessions and it cannot be dissolved in the same way. Which suits a person depends on whether they want immediate, adjustable correction in a specific spot or gradual, broader volume change, and on how they weigh reversibility.

Key points

  • Hyaluronic acid filler is a gel that fills; Sculptra is a collagen stimulator.
  • Sculptra in its US trial was given in up to four sessions, three weeks apart.
  • In that trial, improvement largely held to 25 months for most participants.
  • Hyaluronidase can break down hyaluronic acid filler; non-hyaluronic acid fillers are harder to remove.
  • Lumps (papules or nodules) are a recognised risk with Sculptra.

How they work differently

Hyaluronic acid is a water-binding sugar molecule that occurs naturally in skin. As a filler, it is made into a gel and injected where volume is wanted, and the effect is largely immediate. The body gradually absorbs it, so repeat treatments may be needed to keep the result, with duration depending on the product and the area injected.3

Sculptra contains microparticles of poly-L-lactic acid (PLLA), a synthetic, biodegradable polymer. The particles provoke a controlled, low-level inflammatory response that stimulates collagen to be laid down in the surrounding tissue, restoring volume gradually.2

FeatureHyaluronic acid fillerSculptra (PLLA)
How it worksGel fills the space directly3Stimulates the body’s own collagen2
When change is seenLargely immediateBuilds over a course of sessions1
Typical courseOften one session, with later top-upsUp to four sessions, three weeks apart, in the US trial1
Can it be dissolved?Yes, with hyaluronidase4No equivalent enzyme; removal is harder3
Suited toTargeted areas such as lips, cheeks, chinBroader areas of volume loss and folds
Notable riskBlood vessel blockage (both fillers)3Papules and nodules1
Hyaluronic acid filler and Sculptra compared. Individual products and techniques vary.

What the evidence says about results and duration

Sculptra was first approved in the US in 2004 for facial fat loss in people with HIV, and in 2009 for cosmetic correction of nasolabial folds (the lines from nose to mouth corner) and other facial wrinkles.1 The cosmetic approval rested on a randomised, evaluator-blinded trial of 233 people, with 13 months of controlled follow-up and an extension to 25 months.1

In that trial, the average improvement grew with each session. For people starting with mild or moderate folds, the improvement seen at 13 months was largely still present at 25 months; for those with the deepest folds, it had faded towards baseline by 25 months.1 Participants received an average of 3.2 sessions.1

The evidence that Sculptra produces longer-lasting correction than hyaluronic acid filler in a given area is Limited, because head-to-head comparisons are few and durations vary widely by hyaluronic acid product and site.3

Risks and reversibility

After a first Sculptra session, most trial participants recorded swelling (81%), tenderness (81%), redness (78%), pain (71%) and bruising (65%) in the following two weeks.1 Papules or nodules (small lumps under the skin) developed in 17% of Sculptra participants compared with 13% in the control group, and post-marketing reports include serious granulomas (inflammatory lumps), infections and scarring.1 People prone to keloids or raised scarring should not have it.1

Any filler can block a blood vessel if injected into it, risking tissue death, blindness or stroke.3 With hyaluronic acid, the enzyme hyaluronidase can be used to dissolve the blockage, and protocols using repeated high doses have been described.4 The US regulator notes that fillers not made of hyaluronic acid can be more difficult to remove.3

Common questions

Is Sculptra a filler?

It is regulated as an injectable dermal filler, but it acts mainly by stimulating collagen rather than by filling directly.12

Why does Sculptra need several sessions?

Because the collagen response builds gradually, treatment is spaced out; in the US trial, sessions were repeated every three weeks until correction was reached, up to four times.1

Can Sculptra be used in the lips?

Its US approval covers nasolabial folds and other facial wrinkles, not the lips.1 For lips, see what to expect from lip filler.

What if I do not like the result?

Hyaluronic acid filler can usually be dissolved; Sculptra cannot be reversed in the same way. See can dermal fillers be dissolved.

Bottom line

Hyaluronic acid filler gives immediate, targeted and usually reversible volume, while Sculptra gives gradual, collagen-based change over several sessions that may last longer but cannot be dissolved. The choice turns on the area, the kind of volume loss and how much weight a person places on reversibility.

Sources

  1. US Food and Drug Administration. Summary of Safety and Effectiveness Data: SCULPTRA Aesthetic (P030050/S002). FDA; 2009. https://www.accessdata.fda.gov/cdrh_docs/pdf3/P030050S002b.pdf. Accessed 5 November 2026.
  2. Fitzgerald R, Bass LM, Goldberg DJ, Graivier MH, Lorenc ZP. Physiochemical Characteristics of Poly-L-Lactic Acid (PLLA). Aesthetic Surgery Journal; 2018;38(suppl 1):S13–S17. https://doi.org/10.1093/asj/sjy012
  3. US Food and Drug Administration. Dermal Fillers (Soft Tissue Fillers). FDA. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/dermal-fillers-soft-tissue-fillers. Accessed 5 November 2026.
  4. DeLorenzi C. New High Dose Pulsed Hyaluronidase Protocol for Hyaluronic Acid Filler Vascular Adverse Events. Aesthetic Surgery Journal; 2017;37(7):814–825. https://doi.org/10.1093/asj/sjw251

Article history

  • — First published.